EQV Ventures II

This filing establishes the post-IPO operating baseline for EVAC, locking in trust mechanics, sponsor alignment through waived insider claims, and the precise statutory triggers governing shareholder redemption versus liquidation. The documented $40,000 monthly expense rate and available up-to-$1,500,000 convertible working capital loans define the pre-combination cash burn trajectory, while the explicit 24-month operational window sets the maximum timeline before mandatory liquidation procedures activate. Management's acknowledgment that no operations have commenced and all historical activity pertains solely to IPO formation and preparation confirms the entity remains in the pure target-search phase, making trust preservation, redemption valuation tracking, and deadline management the primary near-term investor considerations. The underwriters' and sponsor's contractual waivers of trust-distributed assets further de-risk potential dilution to public shareholders should the combination timeline expire.

This filing sets the foundational terms for the SPAC, including trust value, redemption rights, and sponsor economics. Investors need to understand the high dilution from founder shares ($0.002 vs. $10.00 public), the 24-month deadline with extension possibility, and the significant conflicts of interest with the parallel SPAC EQV I. The energy-focused strategy and the trust per share of $10.00 (not $10.27 as previously noted in the corpus) are critical for redemption calculations.

This filing establishes the foundational structure of the SPAC, including the trust account size, redemption mechanics, warrant terms, lock-up periods, sponsor commitments, and director appointments. It provides the baseline for all future redemption calculations, extension votes, and business combination disclosures. Investors now have a live security with a known per-share trust value and a hard deadline for a deal.

Because the Registrant certified the immediate effectiveness of these 8,050,000 newly registered units upon SEC filing, the public float and warrant coverage expand without restructuring the existing trust or redemption framework. According to the filing, this capital deployment mechanism increases proceeds available to fund ongoing target searches until the stated deadline, while establishing 8,050,000 additional derivative instruments with a $11.50 exercise price. The document contains no claims regarding revenue, customer contracts, technology, strategic partnerships, litigation, or personnel appointments. Consequently, investor attention remains fixed on the pre-established redemption calendar and sponsor execution capacity rather than any near-term business combination timeline.

These contractual terms directly dictate capital allocation, sponsor alignment, and shareholder exit pathways ahead of any target identification. The June 30, 2025 hard stop creates a definitive near-term execution deadline separate from the broader charter expiration, meaning operational delay risks immediate dissolution rather than prolonged searching. Attributed to the agreement signed by Chief Executive Officer Jerome Silvey and President/Chief Financial Officer Tyson Taylor, the document confirms BTIG, LLC’s underwriting appointment, applies Cayman Islands exclusive jurisdiction, and locks warrant pricing at $11.50 per share. The indemnification language and permitted-interest withdrawal caps explicitly safeguard trust assets against third-party claims and administrative drainage, while the forfeiture formula mathematically ensures Sponsor equity maintains a 20% post-IPO baseline unless over-allotment exercises modify the denominator. No customer bases, revenue projections, technology pipelines, or partnership announcements are included, as the filing concentrates exclusively on structural capital preservation, transfer restrictions, and regulatory readiness for an anticipated New York Stock Exchange listing.

Per the letter, the SEC staff’s scrutiny of insider voting commitments indicates that post-filing share acquisitions by management or affiliates may fall outside the original pro-combination voting pledge if the Rule 14e-5 exemption applies. This directly impacts redemption dynamics and control margins at a future business combination vote, as unpledged insider shares could shift the mathematical threshold for shareholder approval. The request for amendment introduces a procedural hold on S-1 effectiveness, delaying capital deployment and extending the firm’sSEARCHING phase until the Division of Corporation Finance reviews the response. The correspondence is addressed to Chief Executive Officer Jerome Silvey, placing direct executive responsibility on aligning the registration disclosures. The document contains no claims regarding customers, revenue, market size, strategy, technology, partnerships, or litigation.

Sets the redemption calendar: trust initially $10.00 per share; deadline 24 months from offering close (projected mid-2027); extensions require shareholder vote with redemption rights. Provides all mechanical terms investors need to track potential redemption events, trust value, and sponsor conduct. Material because it defines the entire investment structure for this SPAC.

The regulatory correspondence confirms active IPO formulation while exposing precise friction points that dictate redemption economics and timeline risk. The staff's explicit focus on the 12-month versus 24-month administrative cost gap signals scrutiny over whether operating deficits will require trust withdrawals or external borrowing during the unextended portion of the search period. Codified forfeiture risks attached to founder shares and private warrants, paired with up to $1,500,000 in convertible working capital loans, establish a transparent incentive baseline for comparing hold versus redemption valuations. Rule 14e-5 compliance affirmations and membership interest transfer disclosures delineate takeover defense boundaries and control stability, which directly influence liquidity premiums and anchor positioning during the searching phase. Mandatory investment company classification caveats further indicate that regulatory misclassification exposure remains active throughout the lifecycle, reinforcing the necessity of tracking trust deployment velocity and supplemental capital calls as the company advances toward completion.

The filing confirms the SPAC's intent to proceed with its $350 million IPO, its focus on oil & gas exploration and production, a 24-month deadline to complete a business combination (with a possible 36-month extension via shareholder vote), and redemption rights at $10.00 per share. The $10.27 per-share trust value reported in the corpus may reflect interest accretion from the fully-funded trust, but this filing does not confirm that; it states the initial deposit will be $10.00 per unit. The filing is material for investors tracking the EVAC trust, redemption mechanics, and sponsor conduct, as it details sponsor economics, lock-up provisions, and potential conflicts of interest.

These mandatory disclosures directly inform how public shareholders will assess redemption thresholds, trust erosion risks, and sponsor alignment before the search expires. Forcing clarification on off-trust funding beyond the current 12-month expense model reveals whether working capital draws or private placements are anticipated to carry the company toward the full 24-month horizon, a variable that determines remaining trust NAV at any future liquidation date. Defining whether cashless warrant conversions and loan exchanges produce material dilution alters the per-share accounting baseline redemption arbitrageurs compare against the trust payout. Mapping open-market acquisition behavior under federal tender offer rules exposes potential liquidity competition between management accumulation efforts and retail sell orders. Quantifying sponsor wealth at risk if no merger occurs and detailing membership-level control transfer pathways establish whether EQV leadership remains mathematically and legally committed to long-horizon value realization or structurally insulated from early-exit dynamics.

This is the first detailed look at EVAC II's proposed terms and sponsor economics before its IPO. It confirms EVAC II is a new SPAC vehicle with no deal in motion, reveals substantial sponsor/affiliate conflicts with EQV I and the EQV Group, and establishes the trust, redemption, extension, and liquidation mechanics investors will need to track once the SPAC lists. The operative trust baseline in the draft is $10.00 per public share, with the 24-month deadline running from the closing of the offering rather than a fixed calendar date in the filing.

What changed: SEC Schedule 13G beneficial ownership report. The filing identifies Wolverine Asset Management, LLC, Wolverine Holdings, LLC, Christopher L. Gust, and Robert R. Bellick as reporting holders. It contains no language addressing the SPAC’s trust per share, its liquidation deadline, potential extensions, target identification, merger negotiation progress, or sponsor conduct regarding shareholder redemption rights. Why it matters: Under Section 13(d) of the Securities Exchange Act, the Schedule 13G certifies that the listed entities and individuals hold equity interests exceeding statutory disclosure thresholds and asserts they are not acting as a controlling group. For investors tracking EVAC’s search-phase timeline and capital preservation, the excerpt confirms routine regulatory monitoring without disclosing aggregate ownership percentages, purchase prices, or stated investment intent. The absence of any reference to a business combination target or amendment to the trust liquidation date indicates the underlying SPAC structure remains operationally unchanged. Complete filing terms would be necessary to determine whether these holders plan to retain shares, participate in a future redemption, or vote for an extension before the stated deadline expires.

What changed: Quarterly Report on Form 10-Q. The document is the first quarterly report (for Q3 2025) since the SPAC's IPO on July 3, 2025. It reports the closing of the IPO, the private placements, the initial Trust Account balance, and the early operational results. No business combination has been announced or is in progress. Why it matters: Establishes the baseline financial position after the IPO: Trust Account of ~$464.8M, working capital of ~$713,885, and the accrual of interest income. It confirms the sponsor forfeited 575,000 Founder Shares after the over-allotment option expired, fixing the founder share count at 11.5M. The 24-month deadline to complete a deal is July 3, 2027.

What changed: A routine compliance exhibit consisting of a Joint Filing Agreement attached to a Schedule 13G beneficial ownership report for EQV Ventures Acquisition Corp. II. The filing discloses no updates to redemption deadlines, trust value, extension mechanisms, deal progress, or sponsor conduct. The undersigned parties—Magnetar Financial LLC, Magnetar Capital Partners LP, Supernova Management LLC, and David J. Snyderman—via attorney-in-fact Hayley Stein, simply agree to file a consolidated Schedule 13G covering their combined beneficial ownership of EQV Ventures II shares as of September 30, 2025 pursuant to Rule 13d-1(k). Why it matters: No operational, strategic, or timeline disclosures are present. The SPAC remains in the SEARCHING phase, with its 2027-07-03 liquidation deadline and stated trust value of $10.27 per share entirely unaffected by this administrative bundling of reporting obligations. Investors monitoring redemption windows, trust dilution, target acquisitions, or sponsor activism receive no actionable signal from this purely procedural submission.

What changed: A Schedule 13G beneficial ownership report, functioning as a routine compliance exhibit disclosing regulatory holdings. The provided filing text identifies EQV Ventures Sponsor II LLC as the reporting holder but contains no share quantities, percentage thresholds, acquisition dates, or purpose declarations. It does not disclose adjustments to redemption windows, trust account balances, combination deadline extensions, or sponsor governance conduct. Why it matters: Schedule 13G submissions typically mark a statutory ownership threshold crossing that can precede target selection, merger negotiations, or sponsorship capital commitments. Because the excerpt omits the disclosure pages that quantify positions or state the transaction's purpose, it provides no verifiable updates on deal progress, strategic direction, customer or revenue profiles, technology developments, partnership arrangements, or litigation matters.(flagged for human review)

What changed: Form 8-K Current Report accompanying Exhibit 99.1, a press release announcing that holders of EQV Ventures Acquisition Corp. II units may elect to separately trade the Class A ordinary shares and redeemable warrants contained therein, effective August 22, 2025. The filing modifies instrument trading mechanics without amending the redemption calendar, trust account administration, business combination deadline, extension provisions, or sponsor conduct disclosures. Per the NYSE registration schedule embedded in the cover page, each whole redeemable warrant is exercisable for one Class A ordinary share at an exercise price of $11.50. Units that are not separated will continue trading under the symbol EVACU, while separated shares and warrants will list under EVAC and EVACW. The press release directs unit holders to have their brokers contact Continental Stock Transfer & Trust Company to execute the split. Why it matters: Unit separation shifts liquidity dynamics between equity and option components, which can influence retail and institutional allocation decisions ahead of redemption or merger votes. According to the press release issued by Chief Executive Officer Jerry Silvey and President and Chief Financial Officer Tyson Taylor, the company’s acquisition mandate focuses on targeting ‘an oil and gas exploration and production company in North America, Europe or other international markets,’ with management citing expected synergies from EQV Group’s operational platform across the traditional energy spectrum. The submission contains no modifications to the contractual trust mechanism governing shareholder redemptions, nor does it advance, delay, or extend the scheduled timeline for consummating a business combination.

What changed: Quarterly report on Form 10-Q for the quarterly period ended June 30, 2025, filed by SPAC EQV Ventures Acquisition Corp. II. This is the first 10-Q filed by EQV Ventures Acquisition Corp. II since its IPO on July 3, 2025. As such, it establishes a baseline for the pre-IPO period and immediately post-IPO. The financial statements cover the period from inception (September 9, 2024) through June 30, 2025, with the IPO closing on July 3, 2025. The filing confirms the IPO of 46,000,000 units at $10.00 per unit, generating $460 million placed in trust. It details the sale of 400,000 Sponsor Private Placement Units ($4 million) and 387,857 Underwriter Private Placement Units ($3,878,570) to BTIG. It reports transaction costs of $24,491,891 and a trust value of $460,000,000 ($10.00 per share). It notes a share recapitalization on July 1, 2025, increasing Class B shares to 12,075,000, and the partial exercise of the over-allotment on July 3, 2025, reducing founder shares subject to forfeiture to 575,000. The deadline for a business combination is 24 months from the IPO close, or July 2027. Why it matters: This filing is highly material as it is the first comprehensive disclosure post-IPO, establishing the trust value, share structure, and sponsor economics. It confirms the SPAC has a $460 million trust and a 24-month deadline. It provides the baseline for tracking trust value, working capital, and any potential redemption pressure or conduct issues. The specific terms of the underwriting agreement, including the $16.1 million deferred fee, and the sponsor's founder share structure with 575,000 shares still subject to forfeiture, are key mechanics for investors.

What changed: Form 8-K Current Report announcing the consummation of an Initial Public Offering on July 3, 2025, and submitting an audited balance sheet as Exhibit 99.1. The registrant's filing discloses that on July 3, 2025, it completed an IPO of 46,000,000 units at $10.00 per unit, incorporating a partial exercise of the underwriters' over-allotment option for 4,000,000 units. The audited balance sheet reflects $460,000,000 deposited into a U.S. trust account administered by Continental Stock Transfer & Trust Company. Management's charter provisions state public shares carry an initial redemption value of $10.00 per share, accruing pro-rata interest, with redemption rights triggered upon shareholder votes to amend redemption timing/substance or upon failure to execute a transaction within 24 months of IPO closing. Notes to the financial statements confirm the sponsor waives redemption and liquidation rights on founder and private placement shares, underwriters waive $16,100,000 in deferred underwriting commissions upon liquidation, and the sponsor assumes liability to restore trust balances below $10.00 per share net of working capital expenses and taxes following third-party creditor claims. The company also records a $40,000 monthly administrative service fee payable to a sponsor affiliate and discloses 15,333,333 public warrants and 262,619 private placement warrants outstanding, each exercisable at $11.50 per share. Why it matters: This filing establishes the post-IPO operating baseline for EVAC, locking in trust mechanics, sponsor alignment through waived insider claims, and the precise statutory triggers governing shareholder redemption versus liquidation. The documented $40,000 monthly expense rate and available up-to-$1,500,000 convertible working capital loans define the pre-combination cash burn trajectory, while the explicit 24-month operational window sets the maximum timeline before mandatory liquidation procedures activate. Management's acknowledgment that no operations have commenced and all historical activity pertains solely to IPO formation and preparation confirms the entity remains in the pure target-search phase, making trust preservation, redemption valuation tracking, and deadline management the primary near-term investor considerations. The underwriters' and sponsor's contractual waivers of trust-distributed assets further de-risk potential dilution to public shareholders should the combination timeline expire.

What changed: Prospectus (424B4) for the initial public offering of EQV Ventures Acquisition Corp. II, a blank-check company searching for a business combination target, primarily in the energy industry. This is the first prospectus filed for the IPO. It establishes the offering terms: 42,000,000 units at $10.00 per unit, each unit consisting of one Class A ordinary share and one-third of one warrant. $420,000,000 (or $483,000,000 if over-allotment exercised) will be deposited into trust at $10.00 per unit. The trust is invested in U.S. government obligations or money market funds. The deadline to complete an initial business combination is 24 months from closing (July 2027), with a possible extension up to 36 months subject to shareholder approval and redemption rights. The sponsor (EQV Ventures Sponsor II LLC) purchased 12,075,000 Class B founder shares for $25,000 ($0.002 per share) and will buy 400,000 private placement units at $10.00 per unit. The underwriting includes deferred commissions and a $1,000,000 cash payment upon business combination. The prospectus details redemption mechanics, conflict-of-interest disclosures (including the existence of sister SPAC EQV I), and the target strategy focused on upstream oil and gas assets. Why it matters: This filing sets the foundational terms for the SPAC, including trust value, redemption rights, and sponsor economics. Investors need to understand the high dilution from founder shares ($0.002 vs. $10.00 public), the 24-month deadline with extension possibility, and the significant conflicts of interest with the parallel SPAC EQV I. The energy-focused strategy and the trust per share of $10.00 (not $10.27 as previously noted in the corpus) are critical for redemption calculations.

What changed: Form 8-K reporting the closing of the initial public offering (IPO) of EQV Ventures Acquisition Corp. II, including the entry into material definitive agreements, appointment of directors, and adoption of amended charter. The SPAC consummated its IPO on July 3, 2025, selling 46,000,000 units (including 4,000,000 from partial over-allotment exercise) at $10.00 per unit, generating gross proceeds of $460,000,000. Net proceeds of $420,000,000 were deposited into the trust account, resulting in a trust value of approximately $10.27 per share. The company also issued 400,000 sponsor private placement units and 387,857 underwriter private placement units. The board of directors was appointed with Jerome C. Silvey, Jr., Bryan Summers, Andrew Blakeman, and Marc Peperzak; the amended and restated memorandum and articles of association were adopted; and all standard IPO-related agreements were executed (underwriting, warrant, trust, registration rights, insider letter, administrative services). The deadline to complete a business combination is 24 months from the closing (July 2027). Why it matters: This filing establishes the foundational structure of the SPAC, including the trust account size, redemption mechanics, warrant terms, lock-up periods, sponsor commitments, and director appointments. It provides the baseline for all future redemption calculations, extension votes, and business combination disclosures. Investors now have a live security with a known per-share trust value and a hard deadline for a deal.

What changed: Routine compliance exhibit — Form 3, Initial Statement of Beneficial Ownership of Securities (insider ownership report). The submitted filing states that Chief Strategy Officer Andrew McKinley has no non-derivative transactions or equity holdings to disclose, registering zero change to insider share counts. Why it matters: This routine compliance exhibit does not bear on redemption deadlines, trust valuations, extension mechanics, deal search progress, or sponsor conduct. It provides no actionable intelligence for investors tracking liquidation windows or merger development. Beyond confirming the reporting officer’s name and title, the document contains no substantive claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel changes.